Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression

By sjmartinez • February 17, 2023

Khanna D, Maher TM, Volkmann ER, Allanore Y, Smith V, Assassi S, Kreuter M, Hoffmann-Vold AM, Kuwana M, Stock C, Alves M, Sambevski S, Denton CP. Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression. RMD Open. 2023 Feb;9(1):e002859. doi: 10.1136/rmdopen-2022-002859. PMID: 36796874; PMCID: PMC9936273.

Tags: Autoimmune Diseases, Publications, Pulmonary fibrosis, Rheumatology, Scleroderma, Systemic, Therapeutics

Mitochondrial oxidants promote platelet activation and thrombotic susceptibility in prediabetes

Ahmed A, Yadav P, Jensen M, Geasland K, Swamy J, Spitz DR, Abel ED, Jalal D, Dayal S. Mitochondrial oxidants promote platelet activation and thrombotic[...]

DaRE to Approach Differently: Teaching the Digital Anorectal Examination Through a Trauma-Informed Framework

Kwan K, Labora A, Chen F, Solorzano W, Gonzalez D, Orji W, Russell T. DaRE to Approach Differently: Teaching the Digital Anorectal Examination Through a[...]

Facial Swelling in a Young Adult With Type 1 Diabetes: Morbihan Disease as a Scleroderma Mimic

Shammas R, Gudino-Rosales S, Kneiber D, Sarantopoulos GP, Aung T. Facial Swelling in a Young Adult With Type 1 Diabetes: Morbihan Disease as a Scleroderma[...]